SARS-CoV-2 variants of concern are emerging in India

被引：257
作者：
Singh, Jasdeep [1 ]
Rahman, Syed Asad [2 ]
Ehtesham, Nasreen Z. [3 ]
Hira, Subhash [4 ]
Hasnain, Seyed E. [1 ,5 ]
机构：
[1] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India
[2] BioInception, Cambridge, England
[3] Safdarjung Hosp Campus, ICMR Natl Inst Pathol, New Delhi, India
[4] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA
[5] Sharda Univ, Sch Basic Sci & Res, Dept Life Sci, Greater Noida, India
来源：
NATURE MEDICINE | 2021年 / 27卷 / 07期
关键词：
D O I：
10.1038/s41591-021-01397-4
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1131 / 1133
页数：3
相关论文
共 50 条
  • [21] A comparison of transmissibility of SARS-CoV-2 variants of concern
    S. S. Manathunga
    I. A. Abeyagunawardena
    S. D. Dharmaratne
    Virology Journal, 20
  • [22] Immune Profile of SARS-CoV-2 Variants of Concern
    La Porta, Caterina A. M.
    Zapperi, Stefano
    FRONTIERS IN DIGITAL HEALTH, 2021, 3
  • [23] On the evolution of SARS-CoV-2 and the emergence of variants of concern
    Magiorkinis, Gkikas
    TRENDS IN MICROBIOLOGY, 2023, 31 (01) : 5 - 8
  • [24] The Immune Response to SARS-CoV-2 and Variants of Concern
    Torbati, Elham
    Krause, Kurt L.
    Ussher, James E.
    VIRUSES-BASEL, 2021, 13 (10):
  • [25] SARS-CoV-2 variants of concern: the knowns and unknowns
    Lessells, Richard J.
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2021, 40 (03)
  • [26] Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India
    Singh, Urvashi B.
    Rophina, Mercy
    Chaudhry, Rama
    Senthivel, Vigneshwar
    Bala, Kiran
    Bhoyar, Rahul C.
    Jolly, Bani
    Jamshed, Nayer
    Imran, Mohamed
    Gupta, Ritu
    Aggarwal, Praveen
    Divakar, Mohit K.
    Sinha, Subrata
    Arvinden, V. R.
    Bajaj, Anjali
    Shamnath, Afra
    Jain, Abhinav
    Scaria, Vinod
    Sivasubbu, Sridhar
    Guleria, Randeep
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1696 - 1700
  • [27] Emerging SARS-CoV-2 Mutational Variants of Concern Should Not Vary in Susceptibility to Microbicidal Actives
    Ijaz, M. Khalid
    Nims, Raymond W.
    McKinney, Julie
    LIFE-BASEL, 2022, 12 (07):
  • [28] Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern
    Carter-Timofte, Madalina Elena
    Arulanandam, Rozanne
    Kurmasheva, Naziia
    Fu, Kathy
    Laroche, Genevieve
    Taha, Zaid
    van Der Horst, Demi
    Cassin, Lena
    van der Sluis, Renee M.
    Palermo, Enrico
    Di Carlo, Daniele
    Jacobs, David
    Maznyi, Glib
    Azad, Taha
    Singaravelu, Ragunath
    Ren, Fanghui
    Hansen, Anne Louise
    Idorn, Manja
    Holm, Christian K.
    Jakobsen, Martin R.
    van Grevenynghe, Julien
    Hiscott, John
    Paludan, Soren R.
    Bell, John C.
    Seguin, Jean
    Sabourin, Luc A.
    Cote, Marceline
    Diallo, Jean-Simon
    Alain, Tommy
    Olagnier, David
    ACS INFECTIOUS DISEASES, 2021, 7 (11): : 3034 - 3051
  • [29] Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model
    Abdelnabi, Rana
    Foo, Caroline S.
    De Jonghe, Steven
    Maes, Piet
    Weynand, Birgit
    Neyts, Johan
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (05) : 749 - 753
  • [30] Developing pan-β-coronavirus vaccines against emerging SARS-CoV-2 variants of concern
    Su, Shan
    Li, Weihua
    Jiang, Shibo
    TRENDS IN IMMUNOLOGY, 2022, 43 (03) : 170 - 172
12345